Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Higuchi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Iscience|March 30, 2026
Horizontal and vertical gene transfer shape the plasmid host range in surface-associated microbial systemsKohei Takahashi, Kiko Ohara, Kosuke Higuchi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 21, 2023
[A CASE OF URACHAL CARCINOMA WITH HIGH FREQUENCY MICROSATELLITE INSTABILITY (MSI-HIGH) TREATED BY PEMBROLIZUMAB]Takashi Tokita, Shuntaro Iuchi, Noriaki Noto, et al.
Journal of Medical Case Reports|August 9, 2020
An EGFR T790M-mutated lung adenocarcinoma undergoing large-cell neuroendocrine carcinoma transformation after osimertinib therapy: a case reportShinichi Miyazaki, Yasumasa Kuno, Shunsaku Hayai, et al.
Anticancer Research|December 29, 2018
Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203Yasuhide Muto, Tomomi Furihata, Meika Kaneko, et al.
Scientific Reports|April 18, 2023
Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapyShinpei Saito, Shinichi Sakamoto, Kosuke Higuchi, et al.
Scientific Reports|November 22, 2019
Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinomaKosuke Higuchi, Shinichi Sakamoto, Keisuke Ando, et al.
Journal of Pharmacological Sciences|July 13, 2020
JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 functionKentaro Okunushi, Tomomi Furihata, Hanae Morio, et al.
Journal of Clinical Medicine|April 14, 2019
Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate CancerShinichi Sakamoto, Maihulan Maimaiti, Minhui Xu, et al.
Scientific Reports|January 30, 2020
Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinomaMaihulan Maimaiti, Shinichi Sakamoto, Yasutaka Yamada, et al.
Translational Oncology|October 23, 2020
Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancerMasahiro Sugiura, Hiroaki Sato, Atsushi Okabe, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Iscience|March 30, 2026
Horizontal and vertical gene transfer shape the plasmid host range in surface-associated microbial systemsKohei Takahashi, Kiko Ohara, Kosuke Higuchi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 21, 2023
[A CASE OF URACHAL CARCINOMA WITH HIGH FREQUENCY MICROSATELLITE INSTABILITY (MSI-HIGH) TREATED BY PEMBROLIZUMAB]Takashi Tokita, Shuntaro Iuchi, Noriaki Noto, et al.
Journal of Medical Case Reports|August 9, 2020
An EGFR T790M-mutated lung adenocarcinoma undergoing large-cell neuroendocrine carcinoma transformation after osimertinib therapy: a case reportShinichi Miyazaki, Yasumasa Kuno, Shunsaku Hayai, et al.
Anticancer Research|December 29, 2018
Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203Yasuhide Muto, Tomomi Furihata, Meika Kaneko, et al.
Scientific Reports|April 18, 2023
Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapyShinpei Saito, Shinichi Sakamoto, Kosuke Higuchi, et al.
Scientific Reports|November 22, 2019
Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinomaKosuke Higuchi, Shinichi Sakamoto, Keisuke Ando, et al.
Journal of Pharmacological Sciences|July 13, 2020
JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 functionKentaro Okunushi, Tomomi Furihata, Hanae Morio, et al.
Journal of Clinical Medicine|April 14, 2019
Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate CancerShinichi Sakamoto, Maihulan Maimaiti, Minhui Xu, et al.
Scientific Reports|January 30, 2020
Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinomaMaihulan Maimaiti, Shinichi Sakamoto, Yasutaka Yamada, et al.
Translational Oncology|October 23, 2020
Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancerMasahiro Sugiura, Hiroaki Sato, Atsushi Okabe, et al.
Pageof 2